Deep Lens and Ocala Oncology/Florida Cancer Affiliates Collaborate to Expand Clinical Research Program with AI-Based Trial Matching Solution
Retrieved on:
Wednesday, October 20, 2021
Data Management, Other Health, Technology, Pharmaceutical, Practice Management, Oncology, Managed Care, Hospitals, Clinical Trials, Science, Biotechnology, Software, Other Science, Health, Research, Clinical trial, Innovation, EMR, MD, Hematology, Diagnosis, Pathology, Research, Foundation Medicine, Patient, Partnership, Deep Lens Survey, Population, Cancer, ICOP, VIPER, Helmy Eltoukhy, Medical imaging, Ocala Oncology/Florida Cancer Affiliates, Deep Lens, OCALA ONCOLOGY/FLORIDA CANCER AFFILIATES, DEEP LENS
Ocala Oncology/ Florida Cancer Affiliates and Deep Lens today announced that they have entered into a strategic agreement to expand the well-established clinical research program and offering to patients at the Ocala-based practice.
Key Points:
- Ocala Oncology/ Florida Cancer Affiliates and Deep Lens today announced that they have entered into a strategic agreement to expand the well-established clinical research program and offering to patients at the Ocala-based practice.
- Ocala Oncology/Florida Cancer Affiliates specializes in hematology and oncology care and serves patients in the Central Florida area.
- Deep Lens pre-screening and clinical trial matching solution is provided at no cost to oncology practices.
- Deep Lens is a digital healthcare company focused on a groundbreaking approach to faster recruitment of the best-suited cancer patients to clinical trials.